Earnings Per Share (EPS) fell short of estimates at $0.12, compared to the expected $0.21.Revenue exceeded expectations at approximately $122.2 million, despite a year-over-year decline.Adjusted EBITDA and net income both saw decreases, reflecting ongoing financial pressures.Calavo Growers, Inc. (NASDAQ: CVGW) is a key player in the global market for fresh produce, particularly avocados, tomatoes, and papayas. The company also specializes in processed avocado products. As a publicly traded company, CVGW com ...

Exhibit 99.1 Calavo Growers, Inc. Announces First Quarter 2026 Financial Results Management Commentary "Across the first fiscal quarter, we saw sequential improvement in both our Fresh and Prepared segments," said B. John Lindeman, President and Chief Executive Officer of Calavo. "In Fresh, we executed well around seasonal demand, including Super Bowl-related retail opportunities, increasing sales volumes substantially over the prior year while maintaining solid per-unit margins in a pressured pricing envir ...

or Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2026 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ______________________ Commission File Number: 000-33385 CALAVO GROWERS, INC. (Exact name of registrant as specified in its ...

Core Viewpoint - Calavo Growers, Inc. reported a decrease in net sales and net income for the first fiscal quarter of 2026, while showing growth in its Prepared segment and ongoing progress on its merger with Mission Produce [1][4][11]. Financial Performance - Net sales for the first quarter of fiscal 2026 were $122.2 million, down from $154.4 million in the prior year quarter, reflecting a 21% decrease [5][7]. - Fresh segment sales decreased by 25% to $104.7 million, primarily due to a 35% decline in average avocado selling prices, despite a 17% increase in avocado carton volume [5][6]. - Prepared segment sales increased by 20% to $17.5 million, driven by a 21% increase in pounds sold and expansion of customer relationships [5][6]. Profitability Metrics - Gross profit was $15.2 million, or 12% of net sales, compared to $15.7 million, or 10% of net sales, in the prior year quarter [6][7]. - Adjusted net income was $4.8 million, or $0.27 per diluted share, down from $6.3 million, or $0.35 per diluted share, in the prior year quarter [9][33]. - Adjusted EBITDA was $8.0 million, compared to $9.3 million in the prior year quarter [9][35]. Expenses and Costs - Selling, general, and administrative (SG&A) expenses totaled $16.4 million, including $7.2 million of non-recurring expenses, compared to $10.3 million in the prior year quarter [8][7]. - The company managed SG&A expenses effectively, with adjusted expenses down from the prior year [4]. Balance Sheet and Liquidity - As of January 31, 2026, the company had cash and cash equivalents of $47.7 million and total available liquidity of $79.8 million [10]. - Total debt stood at $3.9 million, with no borrowings under the credit facility [10]. Merger Progress - The merger with Mission Produce is progressing, with several required filings completed, and the transaction is expected to close in the third fiscal quarter of 2026, pending regulatory and shareholder approvals [4][11].

Core Insights - The article discusses the recent financial performance of a leading technology company, highlighting a significant increase in revenue and net income compared to the previous year [1] Financial Performance - The company reported a revenue of $50 billion for the last quarter, representing a 20% increase year-over-year [1] - Net income reached $10 billion, which is a 25% increase compared to the same quarter last year [1] - Earnings per share (EPS) rose to $5, up from $4 in the previous year, indicating strong profitability [1] Market Position - The company has strengthened its market position, capturing an additional 5% market share in the technology sector [1] - Increased demand for its products and services has been attributed to the rise in remote work and digital transformation trends [1] Future Outlook - Analysts predict continued growth, with expectations of a 15% increase in revenue for the next fiscal year [1] - The company plans to invest $2 billion in research and development to enhance its product offerings and maintain competitive advantage [1]

Core Viewpoint - Calavo Growers, Inc. plans to release its financial results for the fiscal first quarter ended January 31, 2026, and will file its Form 10-Q after the market closes on March 12, 2026 [1]. Company Overview - Calavo Growers, Inc. is a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole [2]. - The company sells products under the Calavo brand name, proprietary sub-brands, private labels, and store brands [2]. - Founded in 1924, Calavo has a strong culture of innovation, sustainable practices, and market growth [2]. - The company serves various sectors including retail grocery, foodservice, club stores, mass merchandisers, food distributors, and wholesalers worldwide [2]. - Calavo is headquartered in Santa Paula, California, with facilities throughout the U.S. and Mexico [2].

Core Viewpoint - The article emphasizes the importance of investing in safe-haven assets and undervalued dividend-paying consumer staples stocks during periods of market volatility and geopolitical tension [1][2]. Group 1: Investment Strategy - Safe-haven assets like gold, silver, and U.S. Treasuries are recommended for hedging risks, although their effectiveness may vary [1]. - Consumer staples and utilities are considered safe investments due to their inelastic demand and established history of returning capital to shareholders [2]. Group 2: Selected Companies - **United Breweries Co. (CCU)**: - Benzinga Edge Value Score of 98.14, with a current dividend yield of 2.8% and a dividend payout ratio (DPR) of 58.9% [4]. - The stock trades at 16 times earnings and 0.85 times sales, showing positive price action [4]. - CCU shares have increased over 11% recently, with bullish indicators such as a Golden Cross and favorable MACD signals [7]. - **NuSkin Enterprises Inc. (NUS)**: - Benzinga Edge Value Score of 86.96, with a market cap of $540 million and a dividend yield of 2.08% [8]. - The company reduced its dividend payout from $0.39 to $0.06, but the current payout allows for future increases [8]. - NUS shares have risen 15% at the start of the year, indicating bullish momentum [11]. - **Cresud SACIF y A (CRESY)**: - Benzinga Edge Value Score of 93.82, with a dividend yield of over 5% and a DPR of 23.4% [12]. - The company operates in agriculture and real estate, providing diversification during geopolitical tensions [12]. - CRESY shares have formed a Golden Cross, with the 50-day SMA acting as support [15]. - **Weis Markets Inc. (WMK)**: - Benzinga Edge Value Score of 89.87, with a market cap of $1.68 billion and a dividend yield of 2% [16]. - The DPR is 35.79%, allowing potential for future dividend increases [16]. - WMK shares have shown bullish signals, with a breakout above the 50-day SMA and an RSI indicating upward momentum [18]. - **Calavo Growers Inc. (CVGW)**: - Benzinga Edge Value Score of 80.91, with a dividend yield of 3.09% and a DPR of 72% [19]. - The company operates in the fresh produce sector, which is less affected by tariffs [19]. - CVGW shares have surged nearly 20% recently, breaking above key moving averages [21].

Merger Investigations - RAPT Therapeutics will be acquired by GlaxoSmithKline LLC for $58.00 per share, with an estimated aggregate equity value of $2.2 billion. The investigation focuses on whether the RAPT Board breached its fiduciary duties by failing to conduct a fair process and whether the deal provides fair value to shareholders [2] - Calavo Growers will be acquired by Mission Produce, Inc. for $27.00 per share, consisting of $14.85 in cash and 0.9790 shares of Mission for each share of Calavo, valuing Calavo at approximately $430 million. The investigation concerns potential breaches of fiduciary duties by the Calavo Board regarding the fairness of the deal [4] - Penumbra will be acquired by Boston Scientific Corporation in a cash and stock transaction valuing Penumbra at $374 per share, with an enterprise value of approximately $14.5 billion. The investigation examines whether the Penumbra Board failed to conduct a fair process and whether the deal consideration is fair [6] - FONAR Corporation will be acquired by FONAR, LLC and FONAR Acquisition Sub, Inc. for $19.00 per share in an all-cash transaction. The investigation looks into whether the FONAR Board breached its fiduciary duties by not ensuring a fair process and fair value for shareholders [8]

Financial Performance - Full Year 2025 net income from continuing operations increased by 191% to $20.0 million, with adjusted net income rising by 42% to $28.9 million[2][20] - Total net sales for Fiscal Year 2025 decreased to $648.4 million, down from $661.5 million, primarily due to a 4% decline in Fresh segment sales[8][17] - Adjusted EBITDA from continuing operations for Fiscal Year 2025 increased by 12% to $40.8 million, compared to $36.5 million in the prior year[8][20] - Gross profit for Fiscal Year 2025 was $63.7 million, representing 10% of net sales, compared to $67.8 million in the prior year[8][18] - Net sales for the three months ended October 31, 2025, were $124,681,000, a decrease of 26.6% compared to $169,959,000 for the same period in 2024[43] - Gross profit for the three months ended October 31, 2025, was $11,648,000, down 28.5% from $16,290,000 in the prior year[43] - Operating income for the twelve months ended October 31, 2025, increased to $19,611,000, compared to $16,723,000 in 2024, reflecting a 17.9% growth[43] - Net income attributable to Calavo Growers, Inc. for the three months ended October 31, 2025, was $3,817,000, compared to a loss of $139,000 in the same period last year[43] - Adjusted net income from continuing operations for the twelve months ended October 31, 2025, was $28,907,000, up from $20,360,000 in 2024, representing a 42.3% increase[47] - The net income attributable to Calavo Growers, Inc. for the twelve months ended October 31, 2025, was $19.796 million, a substantial increase from $6.796 million in 2024[49] Segment Performance - The Fresh segment experienced a 31% decrease in sales for Q4 2025, totaling $106.3 million, driven by a 19% decline in average price per carton[8][13] - The Prepared segment saw a 20% increase in sales for Q4 2025, reaching $18.4 million, attributed to an 11% increase in sales volume[8][13] Expenses and Costs - SG&A expenses for Fiscal Year 2025 decreased by 16% to $42.1 million, reflecting lower professional fees and reduced headcount-related costs[8][19] - The company incurred $1.105 million in professional fees related to Mexican tax matters for the three months ended October 31, 2025, compared to $0.233 million in 2024, reflecting a significant increase[50] - A charge of $1.801 million was recorded to resolve grower advance balances associated with a tomato program from previous fiscal years, which is not indicative of current operations[55] - Other costs outside the normal course of operations amounted to $1.008 million, primarily related to finance organization recruiting and legal settlement expenses[56] Cash Flow and Assets - Total current assets decreased to $149,426,000 as of October 31, 2025, from $158,579,000 in 2024, a decline of 5.8%[45] - Total liabilities decreased to $83,691,000 as of October 31, 2025, down from $99,343,000 in 2024, a reduction of 15.8%[45] - Cash and cash equivalents increased to $61,155,000 as of October 31, 2025, compared to $57,031,000 in 2024, an increase of 3.7%[45] Strategic Developments - The company announced a strategic combination with Mission Produce, Inc., where shareholders will receive $27.00 per share, consisting of $14.85 in cash and stock[7][9] - The merger is expected to create cost synergies of $25 million and provide shareholders with opportunities for value creation[9][10] - Calavo and Mission are seeking stockholder approvals for a proposed transaction, which may face risks including regulatory approvals and potential delays[27] - The integration of Calavo and Mission's businesses may incur higher costs and challenges than anticipated, affecting expected synergies[27] - Calavo and Mission plan to file a joint proxy statement with the SEC regarding the proposed transaction, urging investors to review the documents carefully[32] Market and Economic Conditions - The company anticipates softer first quarter results for 2026 due to continued strong avocado supply and pricing dynamics[12] - The companies are exposed to various risks such as economic conditions, client spending reductions, and changes in agricultural product prices[27] - The impact of macroeconomic trends, including increased interest rates, may affect borrowing costs and consumer behavior[29] - The companies are subject to enhanced regulatory scrutiny, which could lead to shipment delays and increased costs[29] - The companies are reliant on large customers and key personnel, which poses risks to their operational stability[28] Non-GAAP Measures - Non-GAAP measures such as adjusted EBITDA and adjusted net income are used to provide a clearer view of financial performance, excluding certain unusual items[37][38] - Adjusted EBITDA is calculated by excluding costs related to acquisitions, restructuring, and other one-time items, providing insight into ongoing operations[39] Foreign Currency Impact - The company reported a foreign currency gain of $4,291,000 for the three months ended October 31, 2025, compared to a loss of $3,041,000 in the same period last year[43] - Foreign currency remeasurement gains were $4.291 million for the three months ended October 31, 2025, compared to a loss of $3.041 million in the same period of 2024, indicating a positive shift in currency impact[52] Interest and Tariff Costs - Interest income rose to $(754) thousand for the three months ended October 31, 2025, from $(680) thousand in 2024, while interest expense decreased to $211 thousand from $274 thousand[49] - Costs related to tariffs for the three months ended October 31, 2025, were less than $0.1 million, primarily due to temporary tariffs on goods sourced from Mexico[53] - The company recorded $867 thousand in FDA regulatory hold-related charges for the three months ended October 31, 2025, reflecting unusual and non-recurring costs[54]

Core Viewpoint - The proposed sale of Calavo Growers, Inc. to Mission Produce, Inc. is under investigation to assess whether the offered consideration adequately values the company [1]. Group 1: Transaction Details - Shareholders of Calavo Growers will receive $14.85 in cash and 0.9790 shares of Mission Produce for each share of Calavo they own [1]. - The law firm Kahn Swick & Foti, LLC is examining the adequacy of the transaction and the process leading to it [1]. Group 2: Legal Rights and Contact Information - Individuals who believe the transaction undervalues Calavo Growers can contact Kahn Swick & Foti to discuss their legal rights without any obligation or cost [2]. - Contact details for Kahn Swick & Foti include a toll-free number and a website for further information [2].